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FeatureWith their high selectivity and specificity especially in chiral reactions, natural 
enzymes are superior to all man-made catalysts. There are many reactions 
of interest, however, that just don’t occur in their repertoire. With a range of 
innovative approaches, scientists are now able to create enzymes with entirely 
new activities. Michael Gross reports. 
Evolving new types of enzymesGiven the importance of catalysts 
both for life and for technology, 
attempts to adapt or mimic natural 
enzymes for technological purposes 
have been made for decades. With 
the knowledge of crystal structures 
that have been coming in at ever-
faster rates since the 1960s, 
researchers have been able to tweak 
the geometry of active sites to alter 
an enzyme’s substrate specificity. 
A bigger challenge lies in the 
reactions that nature simply doesn’t 
use, but chemists do, including 
the Diels-Alder ring formation with 
its highly elegant dance of six 
electrons. In the early 1990s, several 
laboratories developed antibodies 
against analogues of the transition 
state of the target reaction. This 
approach is based on the idea that 
stabilising the transition state by Handedness matters: Chiral molecules exist in
other, like human hands. Enzyme catalysis ca
related versions selectively. (Photo: © age fotobinding it to the antibody will lower 
its energy, thus bringing down the 
activation energy of the reaction. 
A few catalytic antibodies, 
also known as abzymes, were 
successfully produced, including two 
catalysing the Diels-Alder reaction. 
However, the approach turned out 
to have serious limitations, which 
include the difficulty of expressing 
antibodies in bacteria, along with 
structural constraints posed by 
the standard immunoglobulin 
architecture and functional 
ones related to the focus on the 
recognition of the transition state.
Thus, abzymes ultimately failed 
to satisfy the ambitions of enzyme 
designers, and attention returned 
to the question of how one could 
create a proper enzyme that doesn’t 
yet exist in nature. two versions that are mirror images of each
n help to produce one of these symmetry-
stock / SuperStock.)Designing Diels-Alderase
Building on their experience in protein 
design algorithms (Curr. Biol. (2012) 
22, R35–R38), David Baker and his 
group at the University of Washington 
at Seattle embarked on designing an 
enzyme for the Diels-Alder reaction 
from first principles (Science (2010) 
329, 309–313). Using the widely 
studied quantum-mechanical 
mechanism of the reaction, they 
identified ideal positions for a 
hydrogen bond acceptor to bind the 
diene (an alkene with two double 
bonds separated by a single bond) 
and for a hydrogen bond donor to 
interact with the dienophile (the 
alkene that reacts with the diene). 
Calculations predicted that these two 
interactions should narrow the energy 
gap between the molecular orbitals 
relevant for the reaction, thereby 
lowering the activation energy.
With the resulting constraints for 
the active site structure, Baker and 
colleagues set their protein design 
algorithm Rosetta to produce proteins 
sequences containing such a site. 
They chose 84 of the designs for 
experimental tests involving synthesis 
of the relevant genes and expression in 
E. coli. Of these, 50 proteins could be 
successfully expressed and purified. 
Only two of the designs actually 
displayed Diels-Alderase activity when 
tested with the substrates on which 
the design was based. 
Based on these two successful 
designs, the researchers could 
improve the catalytic activity by 
mutating amino acids surrounding the 
active site. The most successful of the 
resulting variants turned out to have a 
97% selectivity for the desired product, 
which is one of eight possible isomeric 
forms, and which in the uncatalysed 
reaction would only represent less than 
half of the product yield.
As Baker and colleagues point out 
in their paper, having an enzyme that 
is active in a new kind of chemical 
reaction is only the beginning of new 
endeavours. Established methods 
of protein engineering as well as 
directed evolution (see below) can 
be applied to vary parameters, 
including the substrate specificity 





Docking site: A model of the ‘active site’ where a catalytic rhodium (orange) cyclopenta-
dienyl complex bound to biotin would dock in the streptavidin structure. Of the amino acid 
residues drawn as stick models, residues 112 (shown just above the rhodium complex) and 
121 (below) have proven crucial to the enzymatic activity of the artificial construct (Figure 
reproduced with permission from Hyster et al. Science (2012) 338,500–503.)This process may eventually lead 
to a whole family of novel enzymes 
that will be natural in their biological 
structure but will perform activities 
wholly unprecedented in nature. 
Conferring chirality
Last year, researchers used a 
different approach to create a novel 
metallo-enzyme, which can lend 
chiral specificity to a kind of ligand 
widely used in organic chemistry. 
The groups of Thomas Ward from 
the University of Basel, Switzerland, 
and Tomislav Rovis from Colorado 
State University at Fort Collins, US, 
exploited the natural affinity between 
the protein streptavidin and its ligand 
biotin, linking a cyclopentadienyl 
ligand to the biotin via an amide bond 
(Science (2012) 338, 500–503). The 
cyclopentadienyl anion is an aromatic, 
electron-rich ring compound which 
readily associates with transition 
metal ions, e.g. with iron to form 
ferrocene. Its derivatives are widely 
used in metal-organic chemistry and 
catalysis, but it is difficult to turn this 
highly symmetric compound into 
something that could confer chirality 
in a catalysed reaction. 
Ward and Rovis studied a 
reaction in which a normally inert 
carbon–hydrogen bond in a benzene 
derivative is activated such that a 
second ring can connect that carbon 
atom to a side chain already attached 
to the benzene. As a model substrate 
they used benzhydroxamic acid 
(Ph-CO-NH-OH), with methylacrylate 
as the reaction partner that binds 
to the activated site of the benzene 
and closes the ring. In the reaction, 
the pair of carbon atoms joined by 
a double bond in the methylacrylate 
can insert itself into the new 
ring in two different orientations 
(regioselectivity), and the one closer 
to the ester group will become a 
chiral centre, leading to a total of four 
possible stereoisomers.
Complexes of rhodium liganded 
with a cyclopentadienyl derivative 
on one side and chloride ions on 
the other are known to catalyse this 
reaction. The mechanism requires the 
rhodium to keep the cyclopentadienyl 
ring and to use all three coordination 
sites opposite to it, such that 
there is no space where one could 
introduce a chiral ligand to guide the 
stereochemistry of the reaction. 
By coupling the cyclopentadienyl 
ring to biotin, which in turn naturally binds to the protein streptavidin, 
the researchers created an artificial 
metal enzyme for this reaction in 
the hope that the chiral environment 
of the protein would induce 
stereochemical selectivity in the 
reaction, which otherwise leads to a 
nearly balanced racemate. 
First experiments with the new 
construct gave only traces of 
the desired product. Modelling 
the active site, the researchers 
identified two amino acid side 
chains of streptavidin that are 
located close to the metal and might 
have an influence on the reaction. 
Systematically replacing these with 
acidic side chains, they found that 
a variant with an aspartate residue 
in position 121 achieves good 
reaction yields. “Engineering this 
carboxylate residue proved critical 
as it significantly accelerated the 
rate-determining C–H deprotonation 
step,” explains Ward.
The researchers then mutagenised 
the other amino acid residue close to the site in a bid to improve 
stereoselectivity. In position 112, 
introduction of aromatic side chains 
led to both improved turnover and 
enantiomeric purity of the product. 
Further studies revealed that the four 
rhodium complexes incorporated 
into a streptavidin tetramer act 
completely independently and with 
the same performance parameters. 
As the new enzyme closes a ring 
next to a benzene ring, it could be 
categorised as a benzannulase. 
In a mixture of MOPS buffer and 
methanol, it can also activate certain 
substituted variants of the original 
substrate as well as a bicyclic one 
(i.e. a naphthalene derivative).  
Triangulation tricks
Ring compounds of just three 
carbon atoms (cyclopropane 
compounds) are highly strained 
and therefore unstable. No wonder 
that they are rarely found in nature 
(although plants use a cyclopropane 
amino acid as a precursor for the 
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Natural catalyst: A crystal structure of the enzyme CYP102A1, of which researchers have 
created thousands of variants, including some that produce cyclopropane compounds in-
stead of epoxides. (Image courtesy of Eric M. Brustad and generated in Pymol (The PyMOL 
Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.).)production of the hormone ethylene), 
while organic chemists consider 
them an interesting challenge. 
To create an artificial enzyme to 
meet this challenge, the group of 
Frances Arnold at the California 
Institute of Technology at Pasadena, 
US, started from a large and 
versatile family of enzymes, namely 
the cytochrome P450 enzymes 
(Science (2013) 339, 307–310). 
Behind the bewildering variety of 
chemical reactions catalysed by 
this large family of proteins stands 
a very simple chemical reason. 
These so-called mono-oxygenases 
have a common way of reducing 
one of the two atoms in an oxygen 
molecule to make water. With the 
remaining oxygen atom, evolution 
apparently allowed them to do 
whatever they wanted, such that 
today there are thousands of very 
different redox reactions catalysed 
by these enzymes, which are 
used, for instance, in hormone 
synthesis, processing of fatty acids, 
and decomposition of organic 
substances. 
Some of these reactions lead to 
a reactive species geometrically 
similar to cyclopropane, but with 
an oxygen taking the place of one of the carbon atoms in the triangle, 
known as an epoxide. Specifically, 
these enzymes activate oxygen by 
coordinating the single atom to a 
haem-iron cofactor, from which the 
oxygen is transferred to a carbon–
carbon double bond, with which it 
forms the epoxide. 
Arnold and her coworkers had 
already studied variants of one 
such cytochrome P450 enzyme, 
namely CYP102A1 from Bacillus 
megaterium, in great detail and 
accumulated thousands of variants 
of it, when they embarked on a 
radical change to the catalysed 
reaction. If they could replace the 
oxene ligand on the haem iron 
with the electronically equivalent 
carbene, they reckoned they 
should be able to transfer this to an 
alkene and obtain a cyclopropane 
compound. Moreover, this reaction 
breaks the symmetry of the alkene 
and creates two new chiral centres, 
as long as each side of the C=C  
double bond carries two different 
substituents. With the chiral 
environment of a re-engineered 
cytochrome P450 enzyme, the 
researchers hoped they might 
be able to make this reaction 
selective for one of the four possible stereoisomers. (The non-hydrogen 
substituents can be arranged on the 
same side of the triangle plane (cis) 
or on opposite sides (trans), and 
each of these versions comes as a 
pair of enantiomers (mirror images).) 
Initial experiments showed 
that wild-type CYP102A1 as well 
as some other P450 enzymes 
showed a modest ability to produce 
cyclopropane compounds from 
model substrates (styrene as 
the alkene compound, and ethyl 
diazo acetate as the carbene 
precursor). Screening their library 
of variants systematically, Arnold 
and colleagues identified 92 diverse 
candidates which they tested in 
detail. Out of a final shortlist of ten 
variants, they found that five were 
more active than the wild type and 
showed an interesting range of 
stereoselectivities, with up to 95% 
enantioselectivity. From these, the 
researchers picked one variant for 
detailed investigation of the enzyme 
reaction and further mutagenesis. 
Their results, the authors conclude, 
“suggest that this approach will 
be useful for other synthetically 
important transformations for which 
biological counterparts do not yet 
exist.” 
Organic chemistry has no 
shortage of reactions lacking 
enzyme support. “Among the 
synthetically important reactions 
for which no natural enzymes exist, 
one should mention C–C cross-
coupling reactions as well as olefin 
metathesis. Both these reaction 
classes were awarded Nobel prizes 
in the past few years,” says Ward, 
referring to the inventions of Nobel 
laureates Richard Heck, Ei-ichi 
Negishi, and Akira Suzuki (2010), 
and of Yves Chauvin, Robert Grubbs, 
and Richard Schrock (2005). “With 
synthetic biology applications in 
mind, creating artificial enzymes 
for these reactions would open 
fascinating perspectives to 
complement metabolic pathways 
with these abiotic reactions.”
Pedro Coelho, first author of the 
cyclopropane paper, nominated the 
same two types of reactions, and 
also mentioned the Wittig reaction 
(converting an aldehyde or ketone 
into an alkene, Nobel prize 1979). 
Screening systematically
Once scientists have succeeded 
in producing a novel enzyme, 
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Triangle shapes: The cis (upper) and the trans (lower) versions of the cyclopropane compound 
featured in the work by Arnold and colleagues. Each of these two diastereomers is chiral and 
thus comes in two enantiomers, but the artificial enzyme is highly selective in producing just 
one of the four possible forms. (Images courtesy of Eric M. Brustad and generated in Pymol 
(The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.).)
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Fifty years ago, Ernst Mayr published 
Animal Species and Evolution [1], 
which influenced a generation of 
evolutionary biologists’ thinking 
about speciation. Mayr justified 
the biological species concept, 
described forms of reproductive 
isolation, argued strenuously 
for the importance of allopatric 
divergence compared to parapatric 
or sympatric speciation, affirmed 
the importance of ecological 
sources of natural selection in the 
divergence of populations and 
species, and developed the thesis 
that epistasis for fitness (the ‘unity 
of the genotype’) was so important 
that genetic drift in newly founded 
populations could initiate selection 
toward a new genetic constitution, 
incompatible with that of the 
‘parent’ species. (This hypothesis 
of ‘founder speciation’ gave rise 
to the punctuated equilibrium 
hypothesis, but was later rejected 
by most population geneticists.) 
Mayr identified the ecological basis 
of some forms of reproductive 
isolation, such as differences in 
breeding season or habitat; he 
appeared ambivalent on whether or 
not to interpret sexual isolation as an 
adaptation to prevent hybridization, 
and he implied that postmating 
isolation, and perhaps also sexual 
isolation, may stem from pleiotropic 
effects of the genes underlying 
selected characters. A role for 
sexual selection in mate preference 
had been widely dismissed for 
several decades, and Mayr almost 
completely ignored it. He interpreted 
most hybrid zones as regions 
of secondary contact between 
divergent, previously allopatric 
Book reviewthey can use both design and 
directed evolution to build on 
that achievement, improving the 
performance of the new catalyst or 
shifting its specificity towards new 
tasks. 
Manfred Reetz came to enzyme 
catalysis from organic chemistry, 
with the wishes of synthetic 
chemists in mind. Working at 
the Max Planck Institute for Coal 
Research at Mülheim and at the 
University of Marburg, he spent 
much of the most recent phase of 
his career (until his recent move 
to emeritus status) developing 
high-throughput methods for the 
directed evolution of enzymes 
(Angew. Chem. Int. Ed. (2011) 
50, 138–174). Initially, this work 
aimed at improving thermostability 
for industrial applications, but 
enantioselectivity soon became an 
important target. 
Following a proof-of-principle 
study improving the enantioselectivity 
of a lipase in the mid 1990s, Reetz’s group developed a whole toolkit for 
the directed evolution of enzymes, 
including iterative saturation 
mutagenesis (ISM), which reduces 
the workload of screening by 
focusing saturation mutagenesis on 
the most promising sites. 
The choice of these sites relies 
on the combinatorial active-site 
saturation test (CAST), which 
takes into account the structural 
information relating to the active site 
available from experimental structure 
determination or from computer 
modelling. 
Applying these tools both to 
existing natural enzymes and to de 
novo designed ones on a large scale 
should open up a whole new world 
of enzyme catalysis, meeting many 
of the needs of synthetic chemistry, 
including the synthesis of new 
pharmaceutical agents.
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